SCHEDULE: Artisan Partners Maintains 10.1% Stake in Twist Bioscience

Artisan Partners Asset Management Inc. and its affiliates report a 10.1% beneficial ownership stake in Twist Bioscience Corporation common stock.

Summary

• Artisan Partners Asset Management Inc. and its affiliated entities (Artisan Partners Holdings LP, Artisan Investments GP LLC, and Artisan Partners Limited Partnership) collectively beneficially own 6,217,213 shares of Twist Bioscience Corporation's common stock.
• This represents 10.1% of the class, based on 61,311,704 shares outstanding as of January 27, 2026.
• The reporting persons have shared voting power over 5,234,848 shares and shared dispositive power over all 6,217,213 shares.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
• Artisan Partners Limited Partnership (APLP) is an investment adviser, and the shares are held on behalf of its discretionary clients.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive signal, as it confirms a significant institutional investor's continued confidence in Twist Bioscience, although it is a routine disclosure without new performance data.

Positives

• A significant institutional investor, Artisan Partners, maintains a substantial 10.1% stake in Twist Bioscience, indicating continued confidence.

Negatives

• No specific negative information is disclosed in this beneficial ownership report.

Risks

• NA

Future Outlook

NA

Industry Context

StockSavvy.ai notes that institutional filings like this Schedule 13G provide transparency into significant ownership stakes by major investment firms. Artisan Partners' continued substantial holding in Twist Bioscience suggests a long-term investment thesis in the biotechnology or synthetic biology sector, aligning with trends of institutional capital flowing into innovative life science companies.

Comparison to Industry Standards

• NA (This filing does not contain performance metrics for comparison to industry standards or specific comparable companies/projects.)

Stakeholder Impact

• Shareholders: Confirmation of a significant institutional investor's continued stake may provide a degree of confidence in the company's long-term prospects.

Key Dates

Keywords

Twist Bioscience, Artisan Partners, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Schedule 13G, TBIO